Comment

An Onlooker's Notebook 660

• Viva archaeologia!
• Music from a distance
• Sinister fingers

Leading Article 661

• Clearing the desks

News 662-664

• GMC clears former DDA chairman after patient's overdose death 662
• OFT seeks meeting with wholesalers 662
• Pharmacists are the drug experts, says Medicines Commission chairman 663
• NHS clarifies prescribing for addicts 663
• PPRS price changes 663
• More money to be spent on anti-smoking steps in Wales 663
• Ted Smith for W. H. Smith 664
• Pharmacy visit by Health Secretary 664
• Pharmacy sets out its stall for the millennium in Norfolk 664

Clinical Pharmacy 665-667

• Majority of pharmacists favour OTC emergency contraception, survey finds 665
• Companies endorse WHO's drug donation guidelines 665
• Pharmacists improve heart failure outcome 665
• Study authors query bioequivalence of new steroid inhalers 666
• Concerns over world-wide injection safety 666
• Liquorice and testosterone levels 666
• Is it beneficial to eradicate Helicobacter pylori in non-ulcer dyspepsia? 667
• Electronic ABPI compendium 667
• Study links antidepressants and risk of GI bleeding 667
• Soft mist inhaler 667

Business 668

• Pharmacists confident on smoking cessation advice 668
• Boots seeks further overseas expansion 668
• CP investment boosts profits 668
• Unichem holds training weekend 668

The Society 669

• Law and Ethics Bulletin - Special treatments 669
• Obituaries 669

Broad Spectrum 670

• What a difference a year makes (L. Taylor)

Letters to the Editor 671-72

• Impact of e-commerce 671
• Missed points 671
• Expensive burden 671
• Why the price differential? 671
• Disheartening article 672
• Forget the dinosaurs 672
• Suitability certificate 672

Special Features 673-677

• Nutrition: Folic acid — new roles for a well-known vitamin (P. Mason)

The Conference 678-684

• Hot topic sessions
  • Widespread consensus on pharmacist involvement in emergency contraception 678-679
  • Pharmacist prescribing: how far should we go? 679-680
  •  NHS fraud: all "suspect" exemption claims to be checked 680
  • Cannabis: when will it become a medicine? 681-682
  • Clinical freedom is "dead" 682
• Science symposium 683-684

Forum 685-689

• NACEP 688-689
• Numark conference 685-687
  • Minimum standards to be part of Numark's core objective 685
  • Community pharmacy in perspective 685
  • A formidable force? 685
  • Business is good, says Numark managing director 686
  • Change is vital, Numark pharmacists told 686
  • Baby product initiative succeeding 686
  • Exciting internet 686
  • New complementary medicine initiative 687
  • MIDAS to be Numark-branded 687
  • Key issues identified 687
  • Fascia design well received 687

Products 690

• Sabril SPC 690
• Adrenaline injection 1mg/ml 690
• Discontinued products 690
• Lagap Pharmaceuticals 690
• Celevac tablets 690
• Rebetol 690
• Mentholatum Ibuprofen gel 690
• Zovirax cold sore cream 690
• Centrum Junior 690
• Ready-to-hang containers 690
• Beecham to monitor colds and influenza 690
• Eye-drop dispensers 690

Notice-Board 691-692

• Diary 691
• Official notices 691
• Future events 691
• Reunions 691
• Drug tariff updates 691
• Aston diploma 692
• Appointments 692
• Examination results 692
• Society meetings 692
• Announcements 692
• Wants list 692
• Corrections 692
• Personal 692